REFINE ICD - INCLUSION/EXCLUSION CRITERIA UPDATED TO REFLECT NEW PROTOCOL V12.1

Initial inclusion criteria (eligibility for Holter screening)

•    18 - 80 years old at time of consent

•    History of MI ≥ 2 and ≤ 60 months prior to screening based on ESC/ACCF/AHA/WHF criteria
     (both STEMI and NSTEMI subjects are eligible)

•    Appropriate post-MI management including revascularization where indicated

•    No contra-indication for transvenous ICD placement
     (e.g., mechanical tricuspid valve, known vascular access problems, active sepsis, etc.)
 
•    LVEF 36% - 50% measured 40 days to 60 months after a confirmed MI
                              - 
 3 months after coronary angioplasty or coronary bypass surgery
                              -   6 months of the screening visit (+ 30 day window)

•    Proven, necessary or appropriate medications (e.g. beta-blocker, ACE inhibitor/ARB, statin, and anti-platelet)

•    In normal sinus rhythm (ECG documented) within the two weeks prior to the screening Holter

•    Written informed consent

•    Able and willing to complete the screening Holter, including the six-minute hall walk

Additional inclusion criterion (eligibility for randomization)

•    Abnormal HRT & TWA (core lab interpretation) on Holter performed 2 - 60 months after the index MI
     and the specified time after coronary revascularization

•    In normal sinus rhythm (ECG documented) within the two weeks prior to the screening Holter

•    In normal sinus rhythm for 18 hours of the 24 hr screening Holter

Exclusion criteria (randomization or registry)

•    Use of antiarrhythmic drugs

•    Clinical indication for permanent pacemaker or a cardiac resynchronization device
 
•    Clinical indication for an ICD or cardiac resynchronization ICD

•    Prior implantation of a pacemaker, ICD, or Cardiac Resynchronization device

•    Any condition, in the investigator's judgment, that would limit life expectancy to < 12 months

•    Chronic renal failure (hemodialysis or peritoneal dialysis)

•    Active ischemia that is amenable to revascularization if not previously revascularized

•    Participation in another trial that may interfere with the REFINE ICD results

•    Pregnancy

•    Inability to comply with the follow-up schedule

This year's brand new replica watches uk products will once again hippocampus uk replica watches to the climax, showing the simplicity, atmosphere, balance of beauty, the fake watches city's modern sense of the depths and the perfect combination of the ocean, it is all the rolex replica best.

REFINE ICD Clinical Coordinating Centre: TRW Building GE63, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada  |  Phone: 1-855-426-6328  |  Fax: (403) 210-8140  |  Contact Us
Follow us on: